Azelastine hydrochloride/fluticasone propionate (Dymista®鼻舒達®) 是多個國際及歐洲醫學組織,包括世界過敏組織WAO(World Allergy Organization)、歐洲呼吸學會ERS(European Respiratory Society)和歐洲過敏和氣道疾病研究與教育論壇EUFOREA(European Forum for Research and Education in Allergy and Airway Diseases)等,共同推薦治療中度至嚴重過敏性鼻炎(鼻敏感)的藥物。6
Dymista® Nasal Spray. Prescribing Information. Version May 2024.
Bousquet J, Meltzer E, Couroux P, et al. Onset of action of the fixed combination intranasal azelastine-fluticasone propionate in an allergen exposure chamber. J Allergy Clin Immunol Pract. 2018;6(5):1726-1732.
Meltzer E, Ratner P, Bachert C, et al. Int Arch Allergy Immunol. 2013;161(4):369-377.
Price D, Bousquet J, Bachert C, et al. A new therapy (MP29-02*) effectively targets the entire seasonal allergic rhinitis symptom complex. Clin Transl Allergy. 2013;3(Suppl 2):P45.
Price D, Shah S, Bhatia S, et al. A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis. J Investig Allergol Clin Immunol. 2013;23(7):495-503.
Bousquet J, Schunemann H, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70-80.